Vir

Vir Biotechnology, Inc. (NASDAQ: VIR) is a clinical-stage immunology company headquartered in San Francisco that combines immunologic insights with modern technology platforms to treat and prevent serious infectious diseases and, increasingly, cancer. Its pipeline spans chronic hepatitis B and D, respiratory infections, and dual-masked T-cell engagers for solid tumors, built on antibody, T-cell, innate-immunity, and small interfering RNA (siRNA) platforms. Vir is a research and corporate organization surfaced as a portfolio company of SoftBank Vision Fund; as of this enrichment pass it publishes no public developer API, SDK, MCP server, or developer portal — only its corporate and investor websites.

Vir is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotechnology, Immunology, and Infectious Disease.

Vir’s developer surface includes support and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealth TechBiotechnologyImmunologyInfectious DiseaseOncologyPharmaceuticalsClinical Research

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.8/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.9 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/vir: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Vir Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService
TermsOfService
 PrivacyPolicy
PrivacyPolicy

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: vir
name: Vir
description: 'Vir Biotechnology, Inc. (NASDAQ: VIR) is a clinical-stage immunology company headquartered in San Francisco
  that combines immunologic insights with modern technology platforms to treat and prevent serious infectious diseases and,
  increasingly, cancer. Its pipeline spans chronic hepatitis B and D, respiratory infections, and dual-masked T-cell engagers
  for solid tumors, built on antibody, T-cell, innate-immunity, and small interfering RNA (siRNA) platforms. Vir is a research
  and corporate organization surfaced as a portfolio company of SoftBank Vision Fund; as of this enrichment pass it publishes
  no public developer API, SDK, MCP server, or developer portal — only its corporate and investor websites.'
url: https://raw.githubusercontent.com/api-evangelist/vir/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
image: https://www.vir.bio/themes/default/images/ogimage.jpg
tags:
- Company
- Health Tech
- Biotechnology
- Immunology
- Infectious Disease
- Oncology
- Pharmaceuticals
- Clinical Research
apis: []
common:
- type: DomainSecurity
  url: security/vir-domain-security.yml
- type: Website
  url: https://www.vir.bio
- type: Support
  url: https://www.vir.bio/contact/
- type: TermsOfService
  url: https://www.vir.bio/terms-of-use/
- type: PrivacyPolicy
  url: https://www.vir.bio/privacy-notice/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: enriched
  artifacts_added: 1
  pass: local-v1